Hormone-refractory Prostate Cancer Clinical Trials in Houston, Texas
2 recruitingHouston, Texas
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
Gastric CancerColon CancerTriple Negative Breast Cancer(TNBC)+8 more
SHY Therapeutics30 enrolled3 locationsNCT07705334
Recruiting
Phase 1
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Hormone-refractory Prostate Cancer
Vir Biotechnology, Inc.437 enrolled12 locationsNCT05997615